Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients

Circulation: Cardiovascular Imaging

Volumn 6, Issue 3, 2013, Pages 423-432

  Piehler, Kayla M ^a,b   Wong, Timothy C ^a,b   Puntil, Kathy S ^a   Zareba, Karolina M ^a,b   Lin, Kathie ^a   Harris, David M ^a,b   Deible, Christopher R ^a,b   Lacomis, Joan M ^a,b   Czeyda Pommersheim, Ferenc ^a,b   Cook, Stephen C ^a   Kellman, Peter ^c   Schelbert, Erik B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

MRI; Myocardial delayed enhancement; Myocardial infarction

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOTERIDOL; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; BREATH HELD LATE GANDOLINIUM ENHANCEMENT; BREATHING; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; DEATH; FEMALE; FREE BREATHING MOTION CORRECTED LATE GADOLINIUM ENHANCEMENT; GOLD STANDARD; HEART FAILURE; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOTION; PRIORITY JOURNAL; VULNERABLE POPULATION; ARTIFACT; BREATH HOLDING; CARDIAC GATED IMAGING; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DISEASE COURSE; HEART MUSCLE; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MORTALITY; MYOCARDIAL DELAYED ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; TIME;

MRI; MYOCARDIAL DELAYED ENHANCEMENT; MYOCARDIAL INFARCTION;

ADULT; AGED; ARTIFACTS; BREATH HOLDING; CARDIAC-GATED IMAGING TECHNIQUES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; GADOLINIUM; HEART FAILURE; HETEROCYCLIC COMPOUNDS; HOSPITALIZATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; ODDS RATIO; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESPIRATION; RISK FACTORS; TIME FACTORS;

MLCS; MLOWN;

EID: 84880218245     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.112.000022     Document Type: Article

References (30)

1. Ledesma-Carbayo MJ, Kellman P, Hsu LY, Arai AE, McVeigh ER. Motion corrected free-breathing delayed-enhancement imaging of myo-cardial infarction using nonrigid registration. J Magn Reson Imaging. 2007;26:184-190. (Pubitemid 47235249)
2. Kellman P, AH, Mancini C, McVeigh ER, Arai AE. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myo-cardial infarction compared to turbo spin echo. Magn Reson Med. 2007;57:891-897. (Pubitemid 46709409)
3. Wollny G, Kellman P, Santos A, Ledesma-Carbayo MJ. Automatic motion compensation of free breathing acquired myocardial perfusion data by using independent component analysis. Med Image Anal. 2012;16:1015-1028.
4. Kellman P, Chefd'hotel C, Lorenz CH, Mancini C, Arai AE, McVeigh ER. High spatial and temporal resolution cardiac cine MRI from retrospective reconstruction of data acquired in real time using motion correction and resorting. Magn Reson Med. 2009;62:1557-1564.
5. Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, Raman SV. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC. Cardiovasc Imaging. 2011;4: 269-278.
6. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Arai AE. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012;308:890-896.
7. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733-2743. (Pubitemid 43947991)
8. Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, Siu S, Brown KA. Incidence and prognostic implication of unrecognized myo-cardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118:1011-1020.
9. Kim HW, Klem I, Shah DJ, Wu E, Meyers SN, Parker MA, Crowley AL, Bonow RO, Judd RM, Kim RJ. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med. 2009;6:e1000057.
10. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD. Prognostic significance of de-layed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009;120:2069-2076.
11. Klem I, Shah DJ, White RD, Pennell DJ, van Rossum AC, Regenfus M, Sechtem U, Schvartzman PR, Hunold P, Croisille P, Parker M, Judd RM, Kim RJ. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ Cardiovasc Imaging. 2011;4:610-619.
12. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol. 2009;55:1-16.
13. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM; Gadoversetamide Myocardial Infarction Imaging Investigators. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117:629-637.
14. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:1407-1424.
15. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002. (Pubitemid 29529292)
16. Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging. 2010;3:743-752.
17. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging. 2006;23:298-308. (Pubitemid 43364055)
18. Wong TC, Piehler K, Puntil KS, Moguillansky D, Meier CG, Lacomis JM, Kellman P, Cook SC, Schwartzman DS, Simon MA, Mulukutla SR, Schelbert EB. Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. J Cardiovasc Magn Reson. 2013;15:6.
19. Lee DC, Wu E, Chung Y-C, Simonetti OP, Elliott M, Holly TA, Klocke FJ, Bonow RO. Comparison between single shot TrueFISP and segmented TurboFLASH for the detection of myocardial infarction [abstract]. J Cardiovasc Magn Reson. 2003;5:79-80.
20. Sievers B, Rehwald WG, Albert TS, Patel MR, Parker MA, Kim RJ, Judd RM. Respiratory motion and cardiac arrhythmia effects on diagnostic accuracy of myocardial delayed-enhanced MR imaging in canines. Radiology. 2008;247:106-114.
21. Sievers B, Elliott MD, Hurwitz LM, Albert TS, Klem I, Rehwald WG, Parker MA, Judd RM, Kim RJ. Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation. 2007;115:236-244. (Pubitemid 46105723)
22. Kellman P, Arai AE. Cardiac imaging techniques for physicians: late enhancement. J Magn Reson Imaging. 2012;36:529-542.
23. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
24. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002;47:372-383. (Pubitemid 34116807)
25. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 2002;106:2322-2327. (Pubitemid 35244732)
26. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21-28. (Pubitemid 32056497)
27. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-isch-aemic cardiomyopathies. Eur Heart J. 2005;26:1461-1474. (Pubitemid 41373486)
28. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmermund A, Bruder O, Schüler WO, Barkhausen J. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol. 2005;184: 1420-1426. (Pubitemid 43821809)
29. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. J Am Coll Cardiol. Cardiovasc Imaging. 2011;4:150-156.
30. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.